Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

Prognostic Value of Progranulin in Patients with Colorectal Cancer Treated with Curative Resection.

Koo DH, Do IG, Oh S, Lee YG, Kim K, Sohn JH, Park SK, Yang HJ, Jung YS, Park DI, Jeong KU, Kim HO, Kim H, Serrero G, Chun HK; KBSMC Colorectal Cancer Team.

Pathol Oncol Res. 2018 Oct 30. doi: 10.1007/s12253-018-0520-7. [Epub ahead of print]

PMID:
30378010
2.

Expression of GP88 (progranulin) in serum of prostate cancer patients is associated with Gleason scores and overall survival.

Greither T, Fischer K, Theil G, Marcou M, Holzhausen HJ, Weigelt K, Serrero G, Hicks D, Yue B, Fornara P, Wullich B, Taubert H, Wach S, Lieb V.

Cancer Manag Res. 2018 Oct 5;10:4173-4180. doi: 10.2147/CMAR.S172069. eCollection 2018.

3.

Immunohistochemical Detection of Progranulin (PGRN/GP88/GEP) in Tumor Tissues as a Cancer Prognostic Biomarker.

Serrero G, Hicks D.

Methods Mol Biol. 2018;1806:107-120. doi: 10.1007/978-1-4939-8559-3_8.

PMID:
29956272
4.

Measurement of Circulating Progranulin (PGRN/GP88/GEP) by Enzyme-Linked Immunosorbent Assay and Application in Human Diseases.

Serrero G, Hicks D.

Methods Mol Biol. 2018;1806:95-105. doi: 10.1007/978-1-4939-8559-3_7.

PMID:
29956271
5.

Progranulin levels in blood in Alzheimer's disease and mild cognitive impairment.

Cooper YA, Nachun D, Dokuru D, Yang Z, Karydas AM, Serrero G, Yue B; Alzheimer's Disease Neuroimaging Initiative, Boxer AL, Miller BL, Coppola G.

Ann Clin Transl Neurol. 2018 Apr 2;5(5):616-629. doi: 10.1002/acn3.560. eCollection 2018 May.

6.

A tribute to Dr. Gordon Hisashi Sato (December 24, 1927-March 31, 2017).

Sato JD, Okamoto T, Barnes D, Hayashi J, Serrero G, McKeehan WL.

In Vitro Cell Dev Biol Anim. 2018 Mar;54(3):177-193. doi: 10.1007/s11626-018-0230-1. Epub 2018 Feb 12.

PMID:
29435725
7.

Higher levels of progranulin in cerebrospinal fluid of patients with lymphoma and carcinoma with CNS metastasis.

Kimura A, Takemura M, Serrero G, Yoshikura N, Hayashi Y, Saito K, Inuzuka T.

J Neurooncol. 2018 May;137(3):455-462. doi: 10.1007/s11060-017-2742-z. Epub 2018 Jan 16.

PMID:
29340960
8.

Association between increased serum GP88 (progranulin) concentrations and prognosis in patients with malignant lymphomas.

Yamamoto Y, Goto N, Takemura M, Yamasuge W, Yabe K, Takami T, Miyazaki T, Takeuchi T, Shiraki M, Shimizu M, Adachi S, Saito K, Shibata Y, Nakamura N, Hara T, Serrero G, Saito K, Tsurumi H.

Clin Chim Acta. 2017 Oct;473:139-146. doi: 10.1016/j.cca.2017.07.024. Epub 2017 Aug 18.

PMID:
28823651
9.

Increased cerebrospinal fluid progranulin correlates with interleukin-6 in the acute phase of neuromyelitis optica spectrum disorder.

Kimura A, Takemura M, Saito K, Serrero G, Yoshikura N, Hayashi Y, Inuzuka T.

J Neuroimmunol. 2017 Apr 15;305:175-181. doi: 10.1016/j.jneuroim.2017.01.006. Epub 2017 Jan 12.

PMID:
28100408
11.

Progranulin as a predictive factor of response to chemotherapy in advanced biliary tract carcinoma.

Kim JH, Do IG, Kim K, Sohn JH, Kim HJ, Jeon WK, Lee SR, Son BH, Shin JH, Nam H, Kwon HJ, Kim MS, Hong HP, Serrero G, Koo DH; KBSMC Pancreatobiliary Cancer Team.

Cancer Chemother Pharmacol. 2016 Nov;78(5):1085-1092. Epub 2016 Oct 15.

PMID:
27744566
12.

Determination of GP88 (progranulin) expression in breast tumor biopsies improves the risk predictive value of the Nottingham Prognostic Index.

Serrero G, Hawkins DM, Bejarano PA, Ioffe O, Tkaczuk KR, Elliott RE, Head JF, Phillips J, Godwin AK, Weaver J, Hicks D, Yue B.

Diagn Pathol. 2016 Aug 8;11(1):71. doi: 10.1186/s13000-016-0520-4.

13.

Morphologically and Functionally Distinct Lipid Droplet Subpopulations.

Zhang S, Wang Y, Cui L, Deng Y, Xu S, Yu J, Cichello S, Serrero G, Ying Y, Liu P.

Sci Rep. 2016 Jul 8;6:29539. doi: 10.1038/srep29539.

14.

Signaling Pathway of GP88 (Progranulin) in Breast Cancer Cells: Upregulation and Phosphorylation of c-myc by GP88/Progranulin in Her2-Overexpressing Breast Cancer Cells.

Kim WE, Yue B, Serrero G.

Breast Cancer (Auckl). 2016 May 5;9(Suppl 2):71-7. doi: 10.4137/BCBCR.S29371. eCollection 2015.

15.

GP88 (progranulin): a novel tissue and circulating biomarker for non-small cell lung carcinoma.

Edelman MJ, Feliciano J, Yue B, Bejarano P, Ioffe O, Reisman D, Hawkins D, Gai Q, Hicks D, Serrero G.

Hum Pathol. 2014 Sep;45(9):1893-9. doi: 10.1016/j.humpath.2014.05.011. Epub 2014 Jun 5.

16.

Increased serum GP88 (Progranulin) concentrations in rheumatoid arthritis.

Yamamoto Y, Takemura M, Serrero G, Hayashi J, Yue B, Tsuboi A, Kubo H, Mitsuhashi T, Mannami K, Sato M, Matsunami H, Matuo Y, Saito K.

Inflammation. 2014 Oct;37(5):1806-13. doi: 10.1007/s10753-014-9911-4.

PMID:
24803297
17.

Progranulin (GP88) tumor tissue expression is associated with increased risk of recurrence in breast cancer patients diagnosed with estrogen receptor positive invasive ductal carcinoma.

Serrero G, Hawkins DM, Yue B, Ioffe O, Bejarano P, Phillips JT, Head JF, Elliott RL, Tkaczuk KR, Godwin AK, Weaver J, Kim WE.

Breast Cancer Res. 2012 Feb 8;14(1):R26.

18.

Increased Circulating Level of the Survival Factor GP88 (Progranulin) in the Serum of Breast Cancer Patients When Compared to Healthy Subjects.

Tkaczuk KR, Yue B, Zhan M, Tait N, Yarlagadda L, Dai H, Serrero G.

Breast Cancer (Auckl). 2011;5:155-62. doi: 10.4137/BCBCR.S7224. Epub 2011 Jul 12.

19.

GP88 (PC-Cell Derived Growth Factor, progranulin) stimulates proliferation and confers letrozole resistance to aromatase overexpressing breast cancer cells.

Abrhale T, Brodie A, Sabnis G, Macedo L, Tian C, Yue B, Serrero G.

BMC Cancer. 2011 Jun 9;11:231. doi: 10.1186/1471-2407-11-231.

20.

Proepithelin is an autocrine growth factor for bladder cancer.

Lovat F, Bitto A, Xu SQ, Fassan M, Goldoni S, Metalli D, Wubah V, McCue P, Serrero G, Gomella LG, Baffa R, Iozzo RV, Morrione A.

Carcinogenesis. 2009 May;30(5):861-8. doi: 10.1093/carcin/bgp050. Epub 2009 Feb 23.

21.

Proepithelin regulates prostate cancer cell biology by promoting cell growth, migration, and anchorage-independent growth.

Monami G, Emiliozzi V, Bitto A, Lovat F, Xu SQ, Goldoni S, Fassan M, Serrero G, Gomella LG, Baffa R, Iozzo RV, Morrione A.

Am J Pathol. 2009 Mar;174(3):1037-47. doi: 10.2353/ajpath.2009.080735. Epub 2009 Jan 29.

22.

Dose-dependent effects of alcohol on insulin signaling: partial explanation for biphasic alcohol impact on human health.

He L, Marecki JC, Serrero G, Simmen FA, Ronis MJ, Badger TM.

Mol Endocrinol. 2007 Oct;21(10):2541-50. Epub 2007 Jul 10.

PMID:
17622585
23.

Dynamic activity of lipid droplets: protein phosphorylation and GTP-mediated protein translocation.

Bartz R, Zehmer JK, Zhu M, Chen Y, Serrero G, Zhao Y, Liu P.

J Proteome Res. 2007 Aug;6(8):3256-65. Epub 2007 Jul 3.

PMID:
17608402
24.

Evidence that mono-ADP-ribosylation of CtBP1/BARS regulates lipid storage.

Bartz R, Seemann J, Zehmer JK, Serrero G, Chapman KD, Anderson RG, Liu P.

Mol Biol Cell. 2007 Aug;18(8):3015-25. Epub 2007 May 30.

25.

Rab-regulated interaction of early endosomes with lipid droplets.

Liu P, Bartz R, Zehmer JK, Ying YS, Zhu M, Serrero G, Anderson RG.

Biochim Biophys Acta. 2007 Jun;1773(6):784-93. Epub 2007 Feb 22.

27.
28.

PC cell-derived growth factor (PCDGF/GP88, progranulin) stimulates migration, invasiveness and VEGF expression in breast cancer cells.

Tangkeangsirisin W, Serrero G.

Carcinogenesis. 2004 Sep;25(9):1587-92. Epub 2004 Apr 29.

PMID:
15117809
29.
30.

PC cell-derived growth factor expression in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.

Pan CX, Kinch MS, Kiener PA, Langermann S, Serrero G, Sun L, Corvera J, Sweeney CJ, Li L, Zhang S, Baldridge LA, Jones TD, Koch MO, Ulbright TM, Eble JN, Cheng L.

Clin Cancer Res. 2004 Feb 15;10(4):1333-7.

31.

Expression of PC-cell-derived growth factor in benign and malignant human breast epithelium.

Serrero G, Ioffe OB.

Hum Pathol. 2003 Nov;34(11):1148-54.

PMID:
14652816
32.
33.

Induction of adipose differentiation related protein and neutral lipid droplet accumulation in keratinocytes by skin irritants.

Corsini E, Viviani B, Zancanella O, Lucchi L, Visioli F, Serrero G, Bartesaghi S, Galli CL, Marinovich M.

J Invest Dermatol. 2003 Aug;121(2):337-44.

34.

PC cell-derived growth factor (granulin precursor) expression and action in human multiple myeloma.

Wang W, Hayashi J, Kim WE, Serrero G.

Clin Cancer Res. 2003 Jun;9(6):2221-8.

35.

The growth factor granulin interacts with cyclin T1 and modulates P-TEFb-dependent transcription.

Hoque M, Young TM, Lee CG, Serrero G, Mathews MB, Pe'ery T.

Mol Cell Biol. 2003 Mar;23(5):1688-702.

36.

The granulin-epithelin precursor/PC-cell-derived growth factor is a growth factor for epithelial ovarian cancer.

Jones MB, Michener CM, Blanchette JO, Kuznetsov VA, Raffeld M, Serrero G, Emmert-Buck MR, Petricoin EF, Krizman DB, Liotta LA, Kohn EC.

Clin Cancer Res. 2003 Jan;9(1):44-51.

37.
39.
40.

High density lipoprotein-mediated cholesterol uptake and targeting to lipid droplets in intact L-cell fibroblasts. A single- and multiphoton fluorescence approach.

Frolov A, Petrescu A, Atshaves BP, So PT, Gratton E, Serrero G, Schroeder F.

J Biol Chem. 2000 Apr 28;275(17):12769-80.

42.
43.

Insulin but not IGF-I is required for the maintenance of the adipose phenotype in the adipogenic cell line 1246.

Serrero G, Lepak N.

In Vitro Cell Dev Biol Anim. 1999 Nov-Dec;35(10):642-6.

PMID:
10614875
47.
48.

Inhibition of adipose differentiation by phosphatidylinositol 3-kinase inhibitors.

Xia X, Serrero G.

J Cell Physiol. 1999 Jan;178(1):9-16.

PMID:
9886485
50.

cDNA cloning and expression of a novel family of enzymes with calcium-independent phospholipase A2 and lysophospholipase activities.

Portilla D, Crew MD, Grant D, Serrero G, Bates LM, Dai G, Sasner M, Cheng J, Buonanno A.

J Am Soc Nephrol. 1998 Jul;9(7):1178-86.

Supplemental Content

Loading ...
Support Center